SLNO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Soleno Therapeutics, Inc. and reminds investors of the May 5, 2026 deadline to seek the role of lead plaintiff in a federal securities class action against the company [2][4]. Group 1: Allegations Against Soleno Therapeutics - The complaint alleges that Soleno and its executives violated federal securities laws by making false or misleading statements and failing to disclose significant safety concerns related to the Phase 3 clinical trial program for DCCR [4][11]. - Specific allegations include that the administration of DCCR posed materially greater safety risks than disclosed, and that DCCR had materially lower commercial viability due to undisclosed risks [4][11]. Group 2: Stock Price Impact - Following a critical report by Scorpion Capital on August 15, 2025, Soleno's stock price fell from over $77 per share to approximately $68 per share, a decline of nearly 12% over two trading days [5][11]. - After a patient death was disclosed on September 10, 2025, the stock price dropped from more than $70 per share to about $57 per share, a decline of approximately 19% over two trading days [6][11]. - On November 4, 2025, Soleno reported financial results indicating that the earlier report disrupted the launch trajectory of DCCR, leading to a one-day stock price decline of approximately 27%, from nearly $64 per share to about $47 per share [7][11]. Group 3: Legal Proceedings - The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class, who will oversee the litigation on behalf of the class [8][11]. - Any member of the putative class may move the Court to serve as lead plaintiff or choose to remain an absent class member without affecting their ability to share in any recovery [8][11]. Group 4: Call for Information - Faruqi & Faruqi encourages anyone with information regarding Soleno's conduct, including whistleblowers and former employees, to contact the firm [9][11].